Xstrahl 150 was successfully used to treat lentigo maligna with normal visual acuity post treatment and improved cosmesis.
Lentigo Meligna Case Study
read more
Resources
Cutaneous Squamous Cell Carcinoma Case Study
In this case study, Xstrahl 150 was used to treat two patients with Cutaneous Squamous Cell Carcinoma.
Xstrahl in Action: SARRP Utilized in Laboratory Microbeam Radiation
Microbeam radiation is typically only available at large synchrotron facilities. SARRP brings this research into a regular laboratory, enabling researchers to study open physics and biology questions in this emerging field. See the results of this study, Evaluation of...
Treating the Nasal Ala with Superficial Radiotherapy
Nasal function and cosmesis are important considerations in the quality of life for nasal ala skin cancer patients. Surgery involves tissue loss, which is likely to lead to impaired function and undesired cosmetic results. Superficial radiotherapy can be an effective...
Xstrahl in Action: SARRP Modified for MBRT Experiments
In this study, Minibeam Radiation Therapy at a Conventional Irradiator: Dose-Calculation Engine and First Tumor-Bearing Animals Irradiation, SARRP was modified to be adjustable for MBRT experiments. Researchers had the chance to conduct systematic and comprehensive...
Xstrahl in Action: SARRP Assists in EPR-Mediated Tumor Targeting
[:us]In the study, EPR-Mediated Tumor Targeting using Ultrasmall-hybrid Nanoparticles: From Animal to Human with Theranostic AGuIX Nanoparticles, SARRP was used to experience the therapeutic action of enhanced permeability and retention (EPR)-mediated tumor targeting...
Xstrahl in Action: SARRP Assists in CBCT Radiotherapy
[:us]SARRP was vital in the study, Contrast Enhanced CBCT-Based Fractionated Radiotherapy and Followup Monitor of Orthotopic GBM: a Proof of Concept Study. Significant control of tumor growth and prolongation of mouse survival are clear indicators on the efficacy of...
RADiant in Action: The Dermatology & Laser Center of San Antonio
Over his career, Dr. Steven Davis, medical director of The Dermatology & Laser Center of San Antonio, has performed more than 25,000 skin cancer operations. While surgery is still the primary treatment, it's not always the best option for the patient, especially...
Dermatologist Highlights RADiant Benefits
Over his career, Dr. Steven Davis, medical director of The Dermatology & Laser Center of San Antonio has performed over 25,000 skin cancer operations. While surgery is still the primary treatment, it's not always the best option for the patient, especially people...
Contact Us